NIPH Clinical Trials Search

UMIN ID: UMIN000001439

Registered date:05/01/2009

A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophagus

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedcervical esophageal cancer
Date of first enrollment2008/11/01
Target sample size32
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)5-FU(700mg/m2 d1-4)+ CDDP(70mg/m2 d1) q4w+RT(60Gy) 5-FU(800mg/m2 d1-5)+ CDDP(80mg/m2 d1) q4w


Primary OutcomeOverall survival
Secondary OutcomeTreatment compliance CR rate Progression free survival 3-year larynx preservation survival toxicity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1.have lymph node metastases at neck level II area 2.have active concomitant malignancy 3.A Hbs antigen is positive 4.pregnant or may be pregnant

Related Information


public contact
Name Sadamoto Zenda
Address 6-5-1Kashiwanoha kashiwa chiba Japan
Telephone 03-3411-1111
Affiliation National Cancer Center Hospital East Radiation Oncology Division
scientific contact
Name Masato Fujii
Address 2-5-1Higashigaoka Meguro Tokyo 152-8902, Japan Japan
Telephone 04-7133-1111
Affiliation National Tokyo Medical Center Dept. of Otolaryngology,